Clinical Trial Update: Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tacrolimus- and cyclosporine-based immunoprophylaxis regimens in heart transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Heart Diseases, Heart Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-02-21